Depletion of Tissue Angiotensin-Converting Enzyme Differentially Influences the Intrarenal and Urinary Expression of Angiotensin Peptides

J. Gregory Modrall, Javid Sadjadi, K. Bridget Brosnihan, Patricia E. Gallagher, Chun Hua Yu, Gerald L. Kramer, Kenneth E. Bernstein, Mark C. Chappell

Research output: Contribution to journalArticle

20 Citations (Scopus)

Abstract

The relative contribution of circulating versus tissue renin-angiotensin systems to the tissue expression of angiotensin peptides in the kidney remains unresolved. To address this issue, intrarenal and urinary levels of the peptide products of the renin-angiotensin system were assessed in a tissue angiotensin-converting enzyme knockout (tisACE-/-) mouse model. Systolic blood pressure was significantly lower (64.6±3.6 versus 81.4±4.5 mm Hg; P<0.02) and urinary volume was increased (7.25±0.86 versus 2.86±0.48 mL/d; P<0.001) in tisACE -/- mice compared with wild-type mice. Intrarenal angiotensin II was 80% lower in tisACE-/- mice compared with wild-type mice (5.17±0.60 versus 25.5±2.4 fmol/mg protein; P<0.001). Intrarenal angiotensin I levels also declined by a comparable extent (73%) in the tisACE-/- mice (P<0.01). Intrarenal angiotensin-(1-7) concentrations were similar between the strains, but the ratio of intrarenal angiotensin-(1-7) to angiotensin II and angiotensin I in tisACE-/- mice increased 470% and 355%, respectively, compared with wild-type mice. Urinary excretion of angiotensin II and angiotensin-(1-7) were not different, but the excretion of angiotensin I increased 270% in tisACE-/- mice (P<0.01). These studies suggest 2 potential mechanisms for the reduction of intrarenal angiotensin II in tisACE-/- mice: (1) an attenuated capacity to form angiotensin II by renal angiotensin-converting enzyme and (2) significant depletion of its direct precursor angiotensin I in renal tissue. Sustained intrarenal levels of angiotensin-(1-7) may contribute to chronic hypotension and polyuria in tisACE-/- mice, particularly in the context of depleted angiotensin II in the kidney.

Original languageEnglish (US)
Pages (from-to)849-853
Number of pages5
JournalHypertension
Volume43
Issue number4
DOIs
StatePublished - Apr 2004

Fingerprint

Angiotensins
Peptidyl-Dipeptidase A
Peptides
Angiotensin I
Angiotensin II
Kidney
Renin-Angiotensin System
Blood Pressure
Polyuria
Knockout Mice
Hypotension
angiotensin I (1-7)

Keywords

  • Angiotensin I
  • Angiotensin II
  • Mice
  • Renin-angiotensin system

ASJC Scopus subject areas

  • Internal Medicine

Cite this

Depletion of Tissue Angiotensin-Converting Enzyme Differentially Influences the Intrarenal and Urinary Expression of Angiotensin Peptides. / Modrall, J. Gregory; Sadjadi, Javid; Brosnihan, K. Bridget; Gallagher, Patricia E.; Yu, Chun Hua; Kramer, Gerald L.; Bernstein, Kenneth E.; Chappell, Mark C.

In: Hypertension, Vol. 43, No. 4, 04.2004, p. 849-853.

Research output: Contribution to journalArticle

Modrall, J. Gregory ; Sadjadi, Javid ; Brosnihan, K. Bridget ; Gallagher, Patricia E. ; Yu, Chun Hua ; Kramer, Gerald L. ; Bernstein, Kenneth E. ; Chappell, Mark C. / Depletion of Tissue Angiotensin-Converting Enzyme Differentially Influences the Intrarenal and Urinary Expression of Angiotensin Peptides. In: Hypertension. 2004 ; Vol. 43, No. 4. pp. 849-853.
@article{45b346f4a7ef4c7fb948b618fa086656,
title = "Depletion of Tissue Angiotensin-Converting Enzyme Differentially Influences the Intrarenal and Urinary Expression of Angiotensin Peptides",
abstract = "The relative contribution of circulating versus tissue renin-angiotensin systems to the tissue expression of angiotensin peptides in the kidney remains unresolved. To address this issue, intrarenal and urinary levels of the peptide products of the renin-angiotensin system were assessed in a tissue angiotensin-converting enzyme knockout (tisACE-/-) mouse model. Systolic blood pressure was significantly lower (64.6±3.6 versus 81.4±4.5 mm Hg; P<0.02) and urinary volume was increased (7.25±0.86 versus 2.86±0.48 mL/d; P<0.001) in tisACE -/- mice compared with wild-type mice. Intrarenal angiotensin II was 80{\%} lower in tisACE-/- mice compared with wild-type mice (5.17±0.60 versus 25.5±2.4 fmol/mg protein; P<0.001). Intrarenal angiotensin I levels also declined by a comparable extent (73{\%}) in the tisACE-/- mice (P<0.01). Intrarenal angiotensin-(1-7) concentrations were similar between the strains, but the ratio of intrarenal angiotensin-(1-7) to angiotensin II and angiotensin I in tisACE-/- mice increased 470{\%} and 355{\%}, respectively, compared with wild-type mice. Urinary excretion of angiotensin II and angiotensin-(1-7) were not different, but the excretion of angiotensin I increased 270{\%} in tisACE-/- mice (P<0.01). These studies suggest 2 potential mechanisms for the reduction of intrarenal angiotensin II in tisACE-/- mice: (1) an attenuated capacity to form angiotensin II by renal angiotensin-converting enzyme and (2) significant depletion of its direct precursor angiotensin I in renal tissue. Sustained intrarenal levels of angiotensin-(1-7) may contribute to chronic hypotension and polyuria in tisACE-/- mice, particularly in the context of depleted angiotensin II in the kidney.",
keywords = "Angiotensin I, Angiotensin II, Mice, Renin-angiotensin system",
author = "Modrall, {J. Gregory} and Javid Sadjadi and Brosnihan, {K. Bridget} and Gallagher, {Patricia E.} and Yu, {Chun Hua} and Kramer, {Gerald L.} and Bernstein, {Kenneth E.} and Chappell, {Mark C.}",
year = "2004",
month = "4",
doi = "10.1161/01.HYP.0000121462.27393.f6",
language = "English (US)",
volume = "43",
pages = "849--853",
journal = "Hypertension",
issn = "0194-911X",
publisher = "Lippincott Williams and Wilkins",
number = "4",

}

TY - JOUR

T1 - Depletion of Tissue Angiotensin-Converting Enzyme Differentially Influences the Intrarenal and Urinary Expression of Angiotensin Peptides

AU - Modrall, J. Gregory

AU - Sadjadi, Javid

AU - Brosnihan, K. Bridget

AU - Gallagher, Patricia E.

AU - Yu, Chun Hua

AU - Kramer, Gerald L.

AU - Bernstein, Kenneth E.

AU - Chappell, Mark C.

PY - 2004/4

Y1 - 2004/4

N2 - The relative contribution of circulating versus tissue renin-angiotensin systems to the tissue expression of angiotensin peptides in the kidney remains unresolved. To address this issue, intrarenal and urinary levels of the peptide products of the renin-angiotensin system were assessed in a tissue angiotensin-converting enzyme knockout (tisACE-/-) mouse model. Systolic blood pressure was significantly lower (64.6±3.6 versus 81.4±4.5 mm Hg; P<0.02) and urinary volume was increased (7.25±0.86 versus 2.86±0.48 mL/d; P<0.001) in tisACE -/- mice compared with wild-type mice. Intrarenal angiotensin II was 80% lower in tisACE-/- mice compared with wild-type mice (5.17±0.60 versus 25.5±2.4 fmol/mg protein; P<0.001). Intrarenal angiotensin I levels also declined by a comparable extent (73%) in the tisACE-/- mice (P<0.01). Intrarenal angiotensin-(1-7) concentrations were similar between the strains, but the ratio of intrarenal angiotensin-(1-7) to angiotensin II and angiotensin I in tisACE-/- mice increased 470% and 355%, respectively, compared with wild-type mice. Urinary excretion of angiotensin II and angiotensin-(1-7) were not different, but the excretion of angiotensin I increased 270% in tisACE-/- mice (P<0.01). These studies suggest 2 potential mechanisms for the reduction of intrarenal angiotensin II in tisACE-/- mice: (1) an attenuated capacity to form angiotensin II by renal angiotensin-converting enzyme and (2) significant depletion of its direct precursor angiotensin I in renal tissue. Sustained intrarenal levels of angiotensin-(1-7) may contribute to chronic hypotension and polyuria in tisACE-/- mice, particularly in the context of depleted angiotensin II in the kidney.

AB - The relative contribution of circulating versus tissue renin-angiotensin systems to the tissue expression of angiotensin peptides in the kidney remains unresolved. To address this issue, intrarenal and urinary levels of the peptide products of the renin-angiotensin system were assessed in a tissue angiotensin-converting enzyme knockout (tisACE-/-) mouse model. Systolic blood pressure was significantly lower (64.6±3.6 versus 81.4±4.5 mm Hg; P<0.02) and urinary volume was increased (7.25±0.86 versus 2.86±0.48 mL/d; P<0.001) in tisACE -/- mice compared with wild-type mice. Intrarenal angiotensin II was 80% lower in tisACE-/- mice compared with wild-type mice (5.17±0.60 versus 25.5±2.4 fmol/mg protein; P<0.001). Intrarenal angiotensin I levels also declined by a comparable extent (73%) in the tisACE-/- mice (P<0.01). Intrarenal angiotensin-(1-7) concentrations were similar between the strains, but the ratio of intrarenal angiotensin-(1-7) to angiotensin II and angiotensin I in tisACE-/- mice increased 470% and 355%, respectively, compared with wild-type mice. Urinary excretion of angiotensin II and angiotensin-(1-7) were not different, but the excretion of angiotensin I increased 270% in tisACE-/- mice (P<0.01). These studies suggest 2 potential mechanisms for the reduction of intrarenal angiotensin II in tisACE-/- mice: (1) an attenuated capacity to form angiotensin II by renal angiotensin-converting enzyme and (2) significant depletion of its direct precursor angiotensin I in renal tissue. Sustained intrarenal levels of angiotensin-(1-7) may contribute to chronic hypotension and polyuria in tisACE-/- mice, particularly in the context of depleted angiotensin II in the kidney.

KW - Angiotensin I

KW - Angiotensin II

KW - Mice

KW - Renin-angiotensin system

UR - http://www.scopus.com/inward/record.url?scp=1642460617&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=1642460617&partnerID=8YFLogxK

U2 - 10.1161/01.HYP.0000121462.27393.f6

DO - 10.1161/01.HYP.0000121462.27393.f6

M3 - Article

C2 - 14981053

AN - SCOPUS:1642460617

VL - 43

SP - 849

EP - 853

JO - Hypertension

JF - Hypertension

SN - 0194-911X

IS - 4

ER -